Absolute Quantitation of Glycoforms of Two Human IgG Subclasses Using Synthetic Fc Peptides and Glycopeptides
Immunoglobulins, such as immunoglobulin G (IgG), are of prime importance in the immune system. Polyclonal human IgG comprises four subclasses, of which IgG1 and IgG2 are the most abundant in healthy individuals. In an effort to develop an absolute MALDI-ToF-MS quantitative method for these subclasses and their Fc N-glycoforms, (glyco)peptides were synthesized using a solid-phase approach and used as internal standards. Tryptic digest glycopeptides from monoclonal IgG1 and IgG2 samples were first quantified using EEQYN(GlcNAc)STYR and EEQFN(GlcNAc)STFR standards, respectively. For IgG1, a similar glycopeptide where tyrosine (Y) was isotopically labelled was used to quantify monoclonal IgG1 that had been treated with the enzyme Endo-F2, i.e., yielding tryptic glycopeptide EEQYN(GlcNAc)STYR. The next step was to quantify single subclasses within polyclonal human IgG samples. Although ion abundances in the MALDI spectra often showed higher signals for IgG2 than IgG1, depending on the spotting solvent used, determination of amounts using the newly developed quantitative method allowed to obtain accurate concentrations where IgG1 species were predominant. It was observed that simultaneous analysis of IgG1 and IgG2 yielded non-quantitative results and that more success was obtained when subclasses were quantified one by one. More experiments served to assess the respective extraction and ionization efficiencies of EEQYNSTYR/EEQFNSTFR and EEQYN(GlcNAc)STYR/EEQFN(GlcNAc)STFR mixtures under different solvent and concentration conditions.
KeywordsImmunoglobulins Glycopeptides MALDI-MS Quantitative analysis Internal standard Glycoproteomics MALDI-ToF-MS Absolute quantitation IgG tryptic digests
The authors would like to thank James Rini (University of Toronto) for providing the Her2SF mAb sample, as well as Michael Butler and Carina Villacrès for providing the Eg2-hFc mAb.
This study was funded by the Natural Sciences and Engineering Council of Canada (NSERC) and the Canadian Foundation for Innovation (CFI).
- 1.Hamilton, R.G.: Human IgG subclass measurements in the clinical laboratory. Clin. Chem. 33, 1707–1725 (1987)Google Scholar
- 4.Schur, P.H.: IgG subclasses. A historical perspective. Monogr. Allergy. 23, 1–11 (1988)Google Scholar
- 7.French, M.A., Harrison, G.: Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin. Exp. Immunol. 56, 473–475 (1984)Google Scholar
- 8.French, M.: Serum IgG subclasses in normal adults. Monogr. Allergy. 19, 100–107 (1986)Google Scholar
- 9.Ferrante, A., Beard, L.J., Feldman, R.G.: IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr. Infect. Dis. J. 9, S16–S24 (1990)Google Scholar
- 12.Remily-Wood, E.R., Benson, K., Baz, R.C., Chen, Y.A., Hussein, M., Hartley-Brown, M.A., Sprung, R.W., Perez, B., Liu, R.Z., Yoder, S.J., Teer, J.K., Eschrich, S.A., Koomen, J.M.: Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients. Proteomics Clin. Appl. 8, 783–795 (2014)CrossRefGoogle Scholar
- 13.Hayes, J.M., Cosgrave, E.F., Struwe, W.B., Wormald, M., Davey, G.P., Jefferis, R., Rudd, P.M.: Glycosylation and Fc receptors. Curr. Top. Microbiol. Immunol. 382, 165–199 (2014)Google Scholar
- 16.Reusch, D., Haberger, M., Falck, D., Peter, B., Maier, B., Gassner, J., Hook, M., Wagner, K., Bonnington, L., Bulau, P., Wuhrer, M.: Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—part 2: mass spectrometric methods. MAbs. 7, 732–742 (2015)CrossRefGoogle Scholar
- 17.Planinc, A., Dejaegher, B., Heyden, Y.V., Viaene, J., Van Praet, S., Rappez, F., Van Antwerpen, P., Delporte, C.: LC-MS analysis combined with principal component analysis and soft independent modelling by class analogy for a better detection of changes in N-glycosylation profiles of therapeutic glycoproteins. Anal. Bioanal. Chem. 409, 477–485 (2017).CrossRefGoogle Scholar
- 19.Stavenhagen, K., Hinneburg, H., Thaysen-Andersen, M., Hartmann, L., Varon Silva, D., Fuchser, J., Kaspar, S., Rapp, E., Seeberger, P.H., Kolarich, D.: Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J Mass Spectrom. 48, 627–639 (2013)CrossRefGoogle Scholar
- 23.Bodnar, E.D., Ferreira Nascimento, T., Girard, L., Komatsu, E., Lopez, P.G., Gomes de Oliveira, A.G., Roy, R., Smythe, T., Zogbi, Y., Spearman, M., Tayi, V.S., Butler, M., Perreault, H.: An integrated approach to analyze EG2-hFc monoclonal antibody N-glycosylation by MALDI-MS. Can. J. Chem. 93, 754–763 (2015)CrossRefGoogle Scholar
- 28.Bosseboeuf, A., Feron, D., Tallet, A., Rossi, C., Charlier, C., Garderet, L., Caillot, D., Moreau, P., Cardó-Vila, M., Pasqualini, R., Arap, W., Nelson, A.D., Wilson, B.S., Perreault, H., Piver, E., Weigel, P., Girodon, F., Harb, J., Bigot-Corbel, E., Hermouet, S.: Monoclonal IgG in MGUS and multiple myeloma target infectious pathogens. JCI Insight. (2017). https://doi.org/10.1172/jci.insight.95367